Jennifer Pietenpol receives award from T.J. Martell Foundation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JENNIFER PIETENPOL was honored with the Medical Research Advancement Award during the T.J. Martell Foundation Nashville Honors Gala. Pietenpol is the B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center.

The award is in recognition of Pietenpol’s career as a cancer researcher. She focuses on the p53 family of proteins and breast cancer, especially triple-negative breast cancer.

Pietenpol joined the Vanderbilt faculty in 1994 and was named director of VICC in 2007. In addition, she has been named to the Institute of Medicine’s National Cancer Policy Forum and is a previous presidential appointee on the National Cancer Advisory Board.

Previously, Pietenpol has received the Burroughs Wellcome New Investigator Award, the Excellence in Teaching Award at Vanderbilt University and the Carleton College Distinguished Alumni Achievement Award. She was inducted into the Johns Hopkins Society of Scholars, and is an elected fellow of the American Association for the Advancement of Science, for work including advances in the understanding of signaling networks in breast and other cancers. She has authored or co-authored over 125 articles published in peer-reviewed scientific literature.

YOU MAY BE INTERESTED IN

By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it.  To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease.  The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login